2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Gary D. Steinberg, MD, Bruce and Beth White family professor, professor of surgery, director, urologic oncology, University of Chicago Medicine, discusses new guidelines for for the management of non-muscle invasive bladder cancer (NMIBC) from the American Urological Association (AUA) and the Society of Urological Oncology (SUO).
The new guidelines were created from a compilation of all of the latest literature and the input of many experts in the field, says Steinberg. The guidelines include information concerning diagnosis, risk stratification, variant histologies, urine markers after diagnosis, intravesical therapy, BCG relapse and salvage regimens, TURBT/repeat resection, role of cystectomy, and risk adjusted surveillance and follow-up strategies.
The guidelines are succinct and straight-forward providing oncologists with a much better understanding as to how patients should be managed and treated.
Related Content: